University of California Researcher Updates Knowledge of Liver Cancer [ATHENA: A phase 1/2 study of AZD5851, a chimeric antigen receptor (CAR) T-cell therapy directed against GPC3 in adult patients with advanced/recurrent hepatocellular ...]

Press/Media

Period2024.07.19

Media coverage

1

Media coverage

  • TitleUniversity of California Researcher Updates Knowledge of Liver Cancer [ATHENA: A phase 1/2 study of AZD5851, a chimeric antigen receptor (CAR) T-cell therapy directed against GPC3 in adult patients with advanced/recurrent hepatocellular ...]
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date24.07.19
    PersonsYong Hong
View all 1
View less